Stock Analysis

Exploring Three Undervalued Small Caps In Australia With Insider Action

ASX:DDR
Source: Shutterstock

In recent trading sessions, the Australian market has shown a relatively flat trajectory with the ASX200 barely moving, reflecting a cautious sentiment among investors. This subdued atmosphere in broader indices contrasts with specific sectors where companies like Narryer Metals and Kingsland Minerals are actively pursuing significant exploration initiatives. In such a market environment, identifying undervalued small-cap stocks can be particularly compelling, especially those where insider actions suggest confidence in future prospects.

Top 10 Undervalued Small Caps With Insider Buying In Australia

Name PE PS Discount to Fair Value Value Rating
Corporate Travel Management 17.3x 2.7x 45.60% ★★★★★★
Tabcorp Holdings NA 0.6x 25.66% ★★★★★★
Neuren Pharmaceuticals 16.2x 11.0x 47.23% ★★★★★☆
Codan 27.4x 4.0x 25.22% ★★★★☆☆
Smartgroup 17.8x 4.4x 47.22% ★★★★☆☆
Eagers Automotive 9.5x 0.3x 29.33% ★★★★☆☆
Tasmea 13.8x 0.9x 15.79% ★★★☆☆☆
Dicker Data 21.6x 0.8x -1.83% ★★★☆☆☆
Coventry Group 289.4x 0.4x -30.11% ★★★☆☆☆
Lynch Group Holdings NA 0.4x -13.03% ★★★☆☆☆

Click here to see the full list of 25 stocks from our Undervalued ASX Small Caps With Insider Buying screener.

We're going to check out a few of the best picks from our screener tool.

Dicker Data (ASX:DDR)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Dicker Data is a wholesale distributor of computer peripherals, with a market capitalization of approximately A$2.27 billion.

Operations: Wholesale of computer peripherals generated A$2.27 billion in revenue, with a gross profit margin of 14.23% as of the latest reporting period. The company's net income for the same period was A$82.15 million, reflecting a net income margin of 3.62%.

PE: 21.6x

Dicker Data, a lesser-known yet promising player in the Australian market, recently saw significant insider confidence as David Dicker acquired 58,165 shares for A$703,674. This move in May underscores a strong belief in the company's prospects amidst its financial landscape characterized by high debt levels and reliance on external borrowing—a riskier funding strategy. Despite these challenges, earnings are expected to grow annually by 7.94%. Moreover, the firm maintained its shareholder commitment by announcing a regular dividend of A$0.11 per share due mid-May.

ASX:DDR Ownership Breakdown as at Jun 2024
ASX:DDR Ownership Breakdown as at Jun 2024

Neuren Pharmaceuticals (ASX:NEU)

Simply Wall St Value Rating: ★★★★★☆

Overview: Neuren Pharmaceuticals is a company focused on the development of pharmaceutical products, with a market capitalization of approximately A$231.94 million.

Operations: Pharmaceutical Products generated A$231.94 million in revenue, with a gross profit margin of 88.47% due to costs of goods sold totaling A$26.75 million. Operating expenses amounted to A$5.95 million for the period.

PE: 16.2x

Recently, Neuren Pharmaceuticals showcased promising results from a Phase 2 clinical trial for NNZ-2591, targeting Pitt Hopkins syndrome—a condition with no approved treatments. Demonstrating statistically significant improvements and a strong safety profile, these findings underscore the company's potential in addressing rare neurological disorders. Notably, insider confidence is reflected through recent share purchases by executives, signaling belief in the company’s trajectory. Amidst this progress, Neuren also actively engaged the investment community with presentations at major conferences.

ASX:NEU Share price vs Value as at Jun 2024
ASX:NEU Share price vs Value as at Jun 2024

Tabcorp Holdings (ASX:TAH)

Simply Wall St Value Rating: ★★★★★★

Overview: Tabcorp Holdings operates primarily in gaming services and wagering, with a focus on the Australian market.

Operations: Gaming Services and Wagering and Media are the primary revenue contributors, generating A$187.8 million and A$2181.7 million respectively. The company has demonstrated a consistently high gross profit margin, averaging approximately 98% over multiple reporting periods, highlighting efficient cost management relative to its revenue generation.

PE: -2.5x

In a display of insider confidence, executives at Tabcorp Holdings recently purchased shares, signaling strong belief in the company's prospects. This Australian firm, known for its lean operations without reliance on customer deposits, faces financial scrutiny with 100% of its liabilities sourced from higher-risk external borrowings. Despite this, earnings are poised to surge by 82% annually. Such growth potential amidst cautious funding strategies paints Tabcorp as a noteworthy player in the undervalued sector.

ASX:TAH Share price vs Value as at Jun 2024
ASX:TAH Share price vs Value as at Jun 2024

Taking Advantage

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com